Department of Health and Social Care (DHSC) has issued a medicine supply notification for Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices
MSN/2024/032
Tier 2 – medium impact
Date of issue: 21st March 2024
Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices are being discontinued with remaining stock exhausted by the end of May 2024.
Humulin® I KwikPen® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled pens remain available and can support increased demand.
Insulatard® Penfill® and Insulatard® vials (insulin isophane human 100units/ml) remain available but cannot support any increased demand.
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
The post Medicine Supply Notification: Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices appeared first on Community Pharmacy England.